Company: LAWIL
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001104659-25-041831
Chunk: 51

Company: Light & Wonder, Inc.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 51
---
 RSUs are scheduled to vest on March 20, 2027, subject to the Company’s achievement by December 31, 2026 of a certain RSU AEBITDA target. For additional information regarding these awards, see “Compensation Discussion and Analysis — Objectives and Components of Compensation Program — Long-Term Incentive Compensation”. The amounts in this column also include the performance-conditioned RSUs granted to Ms. Lane on November 20, 2024, which will vest on March 31, 2028, subject to Ms. Lane’s continued

36

TABLE OF CONTENTS employment through such date and achievement of specified Gaming segment revenue (50% of the RSUs) or AEBITDA (50% of the RSUs) targets measured over each of fiscal year 2025, 2026 and 2027. (3) The amounts shown under the “all other stock awards” column reflect annual grants of time-vesting RSU awards that vest in three substantially equal installments on each of March 20, 2025, and the first two anniversaries of that date for each of the named executive officers. For additional information regarding these awards, see “Compensation Discussion and Analysis — Objectives and Components of Compensation Program — Long-Term Incentive Compensation — Annual Equity Awards”. (4) The amounts shown as the “grant date fair value” of the awards were computed in accordance with FASB ASC Topic 718. The fair value was determined by multiplying the number of shares subject to the award by the average of the high and low sales prices of our common stock on the trading day immediately prior to the grant date. For a discussion of valuation assumptions, see Note 16 to our consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2024. 37

TABLE OF CONTENTS Outstanding Equity Awards at Fiscal Year-End The table below provides information with respect to the stock options and RSUs held by the named executive officers as of December 31, 2024.

| ​              | ​ | ​ | ​          | ​ | ​          | ​ | ​ | ​ | Option Awards                                                  |   |           |   |   |   |                                                                  |   |   |   |   |   |                                                                  |   |   |   |   |   |                           |   |       |   |   |   |                      |   |            |   |   |   |                                                        |